Recall: Teva- Bupropion 300mg - Lower Strength Tablet
Recall Summary Teva-Bupropion XL 300mg tablets are being recalled across Canada due to a product quality issue. This recall affects all bupropion XL 300mg tablets distributed by Teva in Canada. The recall is classified as Class I, meaning there is a potential serious adverse health consequence or death.
- Product
- TEVA-BUPROPION XL 300MG TABLETS
- Reason
- Product quality
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2024-08-09
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/b04d2056-2e13-43f7-9d8c-23e1a52658c3